Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Reports Quarterly Results, Provides Business Outlook

March 29 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES BUSINESS OUTLOOK
    * AETERNA ZENTARIS INC - COMPANY ENDED YEAR WITH $65.3
MILLION IN
CASH, EXPECTED TO FUND OPERATIONS THROUGH 2023
    * AETERNA ZENTARIS INC - FOR THREE-MONTH PERIOD ENDED
DECEMBER 31,
2021, REPORTED CONSOLIDATED NET LOSS OF $2.9 MILLION, OR $0.02
LOSS PER COMMON SHARE
    * AETERNA ZENTARIS INC - TOTAL REVENUE FOR THREE-MONTH
PERIOD
ENDED DECEMBER 31, 2021 WAS $1.0 MILLION AS COMPARED WITH $2.4
MILLION FOR SAME PERIOD IN 2020

Source text for Eikon:  ID:nGNX5FlWvl 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news